Search research articles
Contact Us
Filters
Showing results (81-90 of 160) with videos related to
Page
of 16
Sort By:
Blood
|
May 26, 2005
High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy
Stephanie G Willis, Thoralf Lange, Shadmehr Demehri, et al.
Blood
|
August 23, 2003
In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines
Paul La Rosée, Kara Johnson, Amie S Corbin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 7, 2006
Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib
Paul La Rosée, Taiping Jia, Shadmer Demehri, et al.
Genome Research
|
January 9, 2024
A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data
Yi Qiao, Xiaomeng Huang, Philip J Moos, et al.
Leukemia Research
|
February 9, 2006
Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes
Denise K Walters, Valerie L Goss, Eric P Stoffregen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
January 15, 2019
Drug-free macromolecular therapeutics induce apoptosis in cells isolated from patients with B cell malignancies with enhanced apoptosis induction by pretreatment with gemcitabine
Jiawei Wang, Lian Li, Jiyuan Yang, et al.
Blood
|
June 19, 2008
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease
Anupriya Agarwal, Thomas G P Bumm, Amie S Corbin, et al.
JMIR Research Protocols
|
May 22, 2023
Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review
Jonathan E Constance, Mary M McFarland, Tallie Casucci, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 13, 2009
RNAi screen for rapid therapeutic target identification in leukemia patients
Jeffrey W Tyner, Michael W Deininger, Marc M Loriaux, et al.
Leukemia
|
May 12, 2018
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
William L Heaton, Anna V Senina, Anthony D Pomicter, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 160) with videos related to
Sort By:
Page
of 16
Blood
|
May 26, 2005
High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy
Stephanie G Willis, Thoralf Lange, Shadmehr Demehri, et al.
Blood
|
August 23, 2003
In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines
Paul La Rosée, Kara Johnson, Amie S Corbin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 7, 2006
Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib
Paul La Rosée, Taiping Jia, Shadmer Demehri, et al.
Genome Research
|
January 9, 2024
A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data
Yi Qiao, Xiaomeng Huang, Philip J Moos, et al.
Leukemia Research
|
February 9, 2006
Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes
Denise K Walters, Valerie L Goss, Eric P Stoffregen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
January 15, 2019
Drug-free macromolecular therapeutics induce apoptosis in cells isolated from patients with B cell malignancies with enhanced apoptosis induction by pretreatment with gemcitabine
Jiawei Wang, Lian Li, Jiyuan Yang, et al.
Blood
|
June 19, 2008
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease
Anupriya Agarwal, Thomas G P Bumm, Amie S Corbin, et al.
JMIR Research Protocols
|
May 22, 2023
Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review
Jonathan E Constance, Mary M McFarland, Tallie Casucci, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 13, 2009
RNAi screen for rapid therapeutic target identification in leukemia patients
Jeffrey W Tyner, Michael W Deininger, Marc M Loriaux, et al.
Leukemia
|
May 12, 2018
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
William L Heaton, Anna V Senina, Anthony D Pomicter, et al.
Page
of 16